Archives of Dermatological Research

, Volume 304, Issue 3, pp 237–240 | Cite as

Osteopontin, a protein with cytokine-like properties: a possible involvement in pemphigus vulgaris

  • A. Baroni
  • A. De Filippis
  • E. Buommino
  • R. A. Satriano
  • V. Cozza
Short Communication
First Online:
Received:
Accepted:

Abstract

Pemphigus is an autoimmune blistering disease characterized by severe and chronic course, histopathologically characterized by infiltration of a large quantity of eosinophils, neutrophils, and activated Th1 and Th2 cells around the blister. Polarization of Th cells to Th1 or Th2 phenotypes, a critical aspect of cell-mediated immunity, is influenced by production of early cytokines, including osteopontin. To determine the involvement of osteopontin in pemphigus vulgaris patients in active stage of the disease, auto-antibodies to desmoglein-1 and desmoglein-3 and plasmatic osteopontin levels were examined by ELISA tests. In this work, significant plasmatic level of osteopontin in PV patients with active stage of disease were found particularly in those patients with both skin and oral pemphigus. OPN might drive the immune responses playing an important role in pemphigus onset.

Keywords

Pemphigus vulgaris Osteopontin Desmogleins 
This is a preview of subscription content, log in to check access.

Notes

Conflict of interest

None declared.

References

  1. 1.
    Baroni A, Perfetto B, Ruocco E, Greco R, Criscuolo D, Rocco V (2002) Cytokine pattern in blister fluid and sera of patients with pemphigus. Dermatology 205:116–121PubMedCrossRefGoogle Scholar
  2. 2.
    Buommino E, Tufano MA, Balato N, Canozo N, Donnarumma M, Gallo L, Balato A, Ayala F (2009) Osteopontin: a new emerging role in psoriasis. Arch Dermatol Res 301:397–404PubMedCrossRefGoogle Scholar
  3. 3.
    Comabella M, Pericot I, Goertsches R, Nos C, Castillo M, Blas Navarro J, Río J, Montalban X (2005) Plasma osteopontin levels in multiple sclerosis. J Neuroimmunol 158:231–239PubMedCrossRefGoogle Scholar
  4. 4.
    D’Auria L, Bonifati C, Mussi A, D’Agosto G, De Simone C, Giacalone B, Ferraro C, Ameglio F (1997) Cytokines in the sera of patients with pemphigus vulgaris: interleukin-6 and tumour necrosis factor-α levels are significantly increased as compared to healthy subjects and correlate with disease activity. Eur Cytokine Netw 8:383–387PubMedGoogle Scholar
  5. 5.
    Feliciani C, Toto P, Amerio P, Pour SM, Coscione G, Shivji G, Wang B, Sauder DN (2000) In vitro and in vivo expression of interleukin-1 alpha and tumor necrosis factor-alpha are involved in acantholysis. J Invest Dermatol 114:71–77PubMedCrossRefGoogle Scholar
  6. 6.
    Lanza A, Cirillo N, Femiano F, Gombos F (2006) How does acantholysis occur in pemphigus vulgaris: a critical review. J Cutan Pathol 33:401–412PubMedCrossRefGoogle Scholar
  7. 7.
    Inoue M, Shinohara ML (2011) Intracellular osteopontin (iOPN) and immunity. Immunol Res 49:160–172PubMedCrossRefGoogle Scholar
  8. 8.
    Nishifuji K, Amagai M, Kuwana M, Iwasaki T, Nishikawa T (2000) Detection of antigen-specific B cells in patients with pemphigus vulgaris by enzyme-linked immunospot assay: requirement of T cell collaboration for autoantibody production. J Invest Dermatol 114:88–94PubMedCrossRefGoogle Scholar
  9. 9.
    Puviani M, Marconi A, Cozzani E, Pincelli C (2003) Fas ligand in pemphigus sera induces keratinocyte apoptosis through the activation of caspase-8. J Invest Dermatol 120:164–167PubMedCrossRefGoogle Scholar
  10. 10.
    Rico MJ, Benning C, Weingart ES, Streinlein RD, Hall RP (1999) Characterization of skin cytokines in bullous pemphigoid and pemphigus vulgaris. Br J Dermatol 140:1079–1086PubMedCrossRefGoogle Scholar
  11. 11.
    Sennels H, Sørensen S, Ostergaard M, Knudsen L, Hansen M, Skjødt H, Peters N, Colic A, Grau K, Jacobsen S (2008) Circulating levels of osteopontin, osteoprotegerin, total soluble receptor activator of nuclear factor kappa B ligand, and high-sensitivity C-reactive protein in patients with active rheumatoid arthritis randomized to etanercept alone or in combination with metotraxate. Scand J Rheumatol 37:241–247PubMedCrossRefGoogle Scholar
  12. 12.
    Takeshi E, Minoru H, Yuka S, Makoto I, Kazuhiko T, Shinichi S (2006) Both Th1 and Th2 chemokines are elevated in sera of patients with autoimmune blistering diseases. Arch Dermatol Res 298:38–45CrossRefGoogle Scholar
  13. 13.
    Veldman CM, Gebhard KL, Uter W, Wassmuth R, Grötzinger J, Schultz E, Hertl M (2004) T cell recognition of desmoglein 3 peptides in patients with pemphigus vulgaris and healthy individuals. J Immunol 172:3883–3892PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  • A. Baroni
    • 1
  • A. De Filippis
    • 2
  • E. Buommino
    • 2
  • R. A. Satriano
    • 1
  • V. Cozza
    • 3
  1. 1.Department of DermatologySecond University of NaplesNaplesItaly
  2. 2.Department of Experimental Medicine, Section of Microbiology and Clinical MicrobiologySecond University of Naples (SUN)NaplesItaly
  3. 3.Department of Mathematics and StatisticsUniversity Study of Naples “Federico II”NaplesItaly

Personalised recommendations